Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human

被引:82
作者
Li, Meng [1 ,2 ]
Yuan, Haodan [1 ]
Li, Na [1 ]
Song, Guotao [1 ]
Zheng, Yi [1 ]
Baratta, Mike [1 ]
Hua, Fengmei [1 ]
Thurston, Archie [1 ]
Wang, Joanne [2 ]
Lai, Yurong [1 ]
机构
[1] Pfizer Inc, St Louis Labs, Dept Pharmacokinet Dynam & Drug Metab, Pfizer Global Res & Dev, Chesterfield, MO 63017 USA
[2] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA
关键词
efflux transporters; biliary clearance; interspecies difference; hepatocytes;
D O I
10.1016/j.ejps.2008.06.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The large interspecies differences of hepatobiliary transport present a challenge for the allometric prediction of human biliary excretion for drug candidates primarily cleared via hepatobiliary secretion. In the present study, we determined the metabolic stabilities of common fluorescent substrates of hepatobiliary efflux transporters and developed a rapid efflux assay to determine the functional activities of MRP/Mrp, BCRP/Bcrp and P-gp in hepatocytes of four species. The specificities of transporter-mediated dye efflux were confirmed by selective transporter inhibitors. Among tested species, transporter-specific dye efflux kinetics was consistent between freshly isolated and cryopreserved hepatocytes. Hepatocyte elimination half-lives of MRP/Mrp substrates GS-MF and calcein were observed in the rank order of human > monkey > dog > rat. The fourfold higher MRP/Mrp substrate efflux rate of rat hepatocytes compared to human is likely due to the species-specific functional differences of MRP2/Mrp2 expressed on the canalicular membrane. We also observed efficient BCRP-mediated pheophorbide A (PhA) efflux by human and dog hepatocytes, while PhA extrusion in monkey and rat hepatocytes appeared limited. P-gp function measured by DiOC2(3) efflux was minimal in hepatocytes of all origins and no significant species differences were detected. Our results demonstrated marked differences in hepatocyte MRP/Mrp and BCRP/Bcrp activities across species, indicating that they may contribute to the species differences of in vivo hepatobiliary excretion. These results also suggest the potential utility of primary hepatocytes, either fresh or cryopreserved, as an in vitro model to predict interspecies differences in the biliary transport of MRP/Mrp and BCRP/Bcrp substrates. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:114 / 126
页数:13
相关论文
共 51 条
[31]   Flow cytometric analysis of breast cancer resistance protein expression and function [J].
Minderman, H ;
Suvannasankha, A ;
O'Loughlin, KL ;
Scheffer, GL ;
Scheper, RJ ;
Robey, RW ;
Baer, MR .
CYTOMETRY, 2002, 48 (02) :59-65
[32]  
Minderman H, 1996, CYTOMETRY, V25, P14, DOI 10.1002/(SICI)1097-0320(19960901)25:1<14::AID-CYTO2>3.0.CO
[33]  
2-E
[34]   Functional analysis of dog multidrug resistance-associated protein 2 (Mrp2) in comparison with rat Mrp2 [J].
Ninomiya, M ;
Ito, K ;
Horie, T .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (02) :225-232
[35]   Extensive biliary excretion of the sulfasalazine analogue, susalimod, but different concentrations in the bile duct in various animal species correlating to species-specific hepatobiliary toxicity [J].
Påhlman, I ;
Andersson, S ;
Gunnarsson, K ;
Odell, ML ;
Wilén, M .
PHARMACOLOGY & TOXICOLOGY, 1999, 85 (03) :123-129
[36]   Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport [J].
Pratt, S ;
Chen, V ;
Perry, WI ;
Starling, JJ ;
Dantzig, AH .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (05) :524-532
[37]   Pheophorbide a is a specific probe for ABCG2 function and inhibition [J].
Robey, RW ;
Steadman, K ;
Polgar, O ;
Morisaki, K ;
Blayney, M ;
Mistry, P ;
Bates, SE .
CANCER RESEARCH, 2004, 64 (04) :1242-1246
[38]   A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2) [J].
Robey, RW ;
Honjo, Y ;
van de Laar, A ;
Miyake, K ;
Regis, JT ;
Litman, T ;
Bates, SE .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1512 (02) :171-182
[39]   MULTIDRUG-RESISTANCE AND THE ROLE OF P-GLYCOPROTEIN KNOCKOUT MICE [J].
SCHINKEL, AH ;
MOL, CAAM ;
WAGENAAR, E ;
VANDEEMTER, L ;
SMIT, JJM ;
BORST, P .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) :1295-1298
[40]  
Shilling A. D., 2006, Journal of Pharmacological and Toxicological Methods, V53, P186, DOI 10.1016/j.vascn.2005.08.003